DOCMF - Dr. Martens plc
| Previous Close | 1.7000 |
| Open | 1.7100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.7000 - 1.7000 |
| 52 Week Range | 1.5800 - 3.5100 |
| Volume | |
| Avg. Volume | 11,257 |
| Market Cap | 1.701B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 10.63 |
| EPS (TTM) | 0.1600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.07 (4.25%) |
| Ex-Dividend Date | Jun 08, 2023 |
| 1y Target Est | N/A |
Simply Wall St.Dr. Martens (LON:DOCS) Has Announced A Dividend Of £0.0428
The board of Dr. Martens plc ( LON:DOCS ) has announced that it will pay a dividend on the 18th of July, with investors...
- Simply Wall St.
Dr. Martens plc (LON:DOCS) Pays A UK£0.043 Dividend In Just Two Days
It looks like Dr. Martens plc ( LON:DOCS ) is about to go ex-dividend in the next 2 days. The ex-dividend date is one...
- Simply Wall St.
Dr. Martens Full Year 2023 Earnings: EPS Misses Expectations
Dr. Martens ( LON:DOCS ) Full Year 2023 Results Key Financial Results Revenue: UK£1.00b (up 10% from FY 2022). Net...
The GuardianSales of Dr Martens sandals and shoes soar as boots slide
British brand’s profits tumble after string of errors in US operation hits sales
ReutersLondon stocks start month strong as miners, energy firms rise
British equities gained in a broader market rally on Thursday with higher metal prices supporting miners, while progress on the bill to lift the U.S. debt ceiling further spurred risk appetite. The internationally-focused FTSE 100 gained 0.6% as the U.S. debt ceiling bill successfully passed through the House of Representatives and was headed for a vote in the Senate. "The fact that it looks like the world can put the U.S. debt ceiling silliness behind is certainly a modest positive," said Steve Sosnick, chief strategist at Interactive Brokers.
- Reuters
UPDATE 1-Bootmaker Dr Martens flags hit to profit margins on higher investments
Dr Martens flagged lower profit margins for 2024 fiscal year after the British bootmaker posted a slump in its annual profit on Thursday, citing higher investments to tackle supply chain and operational snags. Dr Martens has also seen its costs mount due to problems at its Los Angeles distribution centre, which opened last year. "The operational issues experienced during FY23 have demonstrated that continuing to invest in our infrastructure and capabilities to support our increasing scale and underpin our long-term growth is the right thing to do," the company said in a statement, adding that it still expects price increases to cover supply chain cost inflation.
ReutersDr Martens tripped up by tough U.S. market
(Reuters) -Dr Martens shares dropped more than 10% on Thursday after the British bootmaker warned investments would hit profit margins this financial year and the consumer backdrop in the United States "was the toughest in the world at the moment". The U.S. is the company's second-largest market and weakness there contributed to a drop in core earnings of more than a quarter in the year ended March 31. Dr Martens, whose pricey work boots have been fashionable since the 1960s, has been struggling with waning demand in the U.S. as consumers cut back on discretionary spending amid high inflation.
- Simply Wall St.
Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
ReutersBootmaker Dr Martens warns on profit as finance chief walks
(Reuters) -Dr Martens issued its third profit warning in five months on Friday, as it struggled with higher-than-expected costs at a new Los Angeles (LA) distribution centre. The British company, whose pricey work boots have been fashionable since the 1960s, also said its Chief Financial Officer Jon Mortimore would leave once it finds a replacement. Mortimore's resignation comes as Dr Martens issued its third profit warning since November, when it flagged a sharp hit to profit margins on weaker-than-expected demand before Christmas.
- Simply Wall St.
Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 28%?
Key Insights Dr. Martens' estimated fair value is UK£1.94 based on 2 Stage Free Cash Flow to Equity Dr. Martens is...
- Simply Wall St.
Is Weakness In Dr. Martens plc (LON:DOCS) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dr. Martens (LON:DOCS) has had a rough three months with its share price down 42%. However, a closer look at its sound...
Motley FoolDr Martens Shares Take a Pummeling
What's more goth than blaming your woes on the sunshine? Dr. Martens, the maker of the steel-toed boots favored by punks, goths, and...
The GuardianDr Martens has shot itself (and London) in the foot with profit warnings
Bootmaker’s reversal of its growth promises has damaged the reputation of the UK IPO market
The TelegraphDr Martens shares plunge to all time low amid warehouse chaos
Dr Martens lost a quarter of its value after it warned on profits as chaos at a new warehouse led to boots piling up.
PA Media: MoneyShares in Dr Martens plummet after it discovers problems at US warehouse
The company has downgraded its outlook for the financial year.
The GuardianDr Martens blames ‘unseasonably warm weather’ amid latest profit warning
Bootmaker’s shares fall as US warehouse problems, along with strikes and staff shortages in Europe, dent profits
Yahoo Finance UKWall Street lower as FTSE 100 closes in the red amid global recession fears
The UK blue chip index finished lower on revived concerns about recession and rate rises.
- Simply Wall St.
Dr. Martens (LON:DOCS) investors are sitting on a loss of 38% if they invested a year ago
Dr. Martens plc ( LON:DOCS ) shareholders should be happy to see the share price up 11% in the last month. But that is...
- Simply Wall St.
Investors Should Be Encouraged By Dr. Martens' (LON:DOCS) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
- Simply Wall St.
Dr. Martens (LON:DOCS) Will Pay A Larger Dividend Than Last Year At £0.0156
Dr. Martens plc ( LON:DOCS ) will increase its dividend on the 3rd of February to £0.0156, which is 28% higher than...
The GuardianDr Martens can’t complain about getting a kicking from investors
Share plunge may look like an overreaction but profits are forecast to fall and the boot maker was clearly overpriced at IPO
The GuardianDr Martens says boot prices will rise to cover increasing costs
Northamptonshire-based footwear group’s half-year results show 5% fall in profits despite 13% rise in sales
Yahoo Finance UKDr Martens plunges 20% as weak demand and strong dollar dents profits
The bootmaker said that its annual core profit margin would be lower than last year as it battles economic headwinds plaguing the retail sector, such as rising inflation and the cost of living crisis.
PA Media: MoneyDr Martens shares slump after bootmaker warns over profit margins
The UK bootmaker said direct-to-consumer sales – those from its own stores and websites – were ‘slower than anticipated’.